MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 145 filers reported holding MACROGENICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,728,000 | -66.5% | 3,975,554 | 0.0% | 0.30% | -58.2% |
| Q1 2022 | $35,025,000 | -45.1% | 3,975,554 | 0.0% | 0.72% | -22.2% |
| Q4 2021 | $63,808,000 | -23.4% | 3,975,554 | 0.0% | 0.93% | -25.7% |
| Q3 2021 | $83,248,000 | +21.7% | 3,975,554 | +56.1% | 1.26% | +21.6% |
| Q2 2021 | $68,410,000 | +6.6% | 2,546,925 | +26.4% | 1.03% | +3.0% |
| Q1 2021 | $64,159,000 | +123.4% | 2,014,400 | +60.3% | 1.00% | +107.9% |
| Q4 2020 | $28,722,000 | -9.2% | 1,256,409 | +0.1% | 0.48% | -36.7% |
| Q3 2020 | $31,621,000 | -9.1% | 1,255,299 | +0.8% | 0.76% | -22.3% |
| Q2 2020 | $34,783,000 | – | 1,245,816 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,215,675 | $6,503,861 | 2.01% |
| Bellevue Group AG | 9,609,913 | $51,413,035 | 0.73% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $9,647,141 | 0.58% |
| ARMISTICE CAPITAL, LLC | 5,600,000 | $29,960,000 | 0.43% |
| Delphia (USA) Inc. | 37,988 | $203,236 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 352,497 | $1,885,859 | 0.31% |
| Corton Capital Inc. | 73,678 | $394,177 | 0.18% |
| Rock Springs Capital Management LP | 1,123,096 | $6,008,564 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 129,158 | $691 | 0.07% |
| PINNACLE ASSOCIATES LTD | 709,903 | $3,797,981 | 0.07% |